Tamoxifen trials for Breast Lobular Carcinoma In Situ

All Tamoxifen trials · All Breast Lobular Carcinoma In Situ trials

Phase breakdown

Recruiting trials studying Tamoxifen for Breast Lobular Carcinoma In Situ

• Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
  NCT05941520 · Phase: Phase 2 · Ages: 35 Years and older · Sex: Female · 4 locations
• Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
  NCT06184750 · Phase: Phase 2 · Ages: 18 Years to 55 Years · Sex: Female · 11 locations
• Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
  NCT06195306 · Phase: Phase 2 · Ages: 45 Years to 74 Years · Sex: Female · 3 locations

Common questions

How many trials study Tamoxifen for Breast Lobular Carcinoma In Situ?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.